Latest Form 4 insider transactions
NYSE
John T Chambers, a Director of Bloom Energy Corp, sold 15,000 shares of common stock on August 13, 2026 for $250.00 per share.
NASDAQ
Rohit Lal, a Director of Proficient Auto Logistics, Inc, purchased 50,000 shares of common stock on August 13, 2026.
NASDAQ
Bradley J. Wright, Chief Financial Officer of Proficient Auto Logistics, Inc, purchased 4,000 shares of common stock on August 13, 2026 for $5.55 per share.
NASDAQ
Amy F. Rice, President and COO of Proficient Auto Logistics, Inc, purchased 995 shares of common stock on August 13, 2026 for $5.55 per share.
Maverick Capital Ltd and 2 others reported changes in beneficial ownership of Churchill Capital Corp X/Cayman common stock on August 4, 2026.
NYSE
Nathaniel A. Vitan, Chief Legal Officer of Public Storage, sold 1,414 shares of common stock on August 13, 2026 for $327.53 per share.
NYSE
ESNT
Essent Group LTDVijay Bhasin, SVP and Chief Risk Officer of Essent Group Ltd., sold 483 shares of common stock on August 7, 2026 for $70.00 per share.
NYSE
Robert Thomas Devincenzi, a Director of Universal Technical Institute Inc, purchased 1,000 shares of common stock on August 12, 2026 for $25.95 per share.
NYSE
Nick Khan, a Director of TKO Group Holdings, Inc., sold 9,589 shares of common stock on August 13, 2026.
NASDAQ
Ghiath M. Sukhtian and 1 other reported changes in beneficial ownership of Outlook Therapeutics, Inc. common stock on August 12, 2026.
NASDAQ
Eric M Demarco, President & CEO and a Director of Kratos Defense & Security Solutions, Inc., sold 300,000 shares of common stock on August 14, 2026.
NASDAQ
Financial For Lutherans Thrivent, a 10% owner of Gloo Holdings, Inc., sold 14,000 shares of common stock on August 12, 2026.
NASDAQ
SYM
Symbotic INCStephen G Pagliuca, a Director of Symbotic Inc., reported multiple transactions in common stock on August 14, 2026.
NASDAQ
Jian Guo, Chief Financial Officer and a Director of Karat Packaging Inc., reported multiple transactions in common stock on August 13, 2026.
NASDAQ
Lawrence A Kenyon, Chief Financial Officer and a Director of Outlook Therapeutics, Inc., purchased 202,020 shares of common stock on August 14, 2026.
NYSE
OPFI
Oppfi INCForm 4: OppFi CEO Buys Shares
Todd G. Schwartz, Chief Executive Officer, a Director and 10% owner of OppFi Inc., purchased 20,000 shares of common stock on August 14, 2026 for $7.20 per share.
NYSE
Form 4: Wayfair CEO Sells Shares
Niraj Shah, Chief Executive Officer and a Director of Wayfair Inc., sold 69,000 shares of common stock on August 12, 2026.
NYSE
Form 4: Wayfair Director Sells Shares
Steven Conine, a Director of Wayfair Inc., sold 69,000 shares of common stock on August 12, 2026.
NASDAQ
Kasra Nejatian, Chief Executive Officer and a Director of Opendoor Technologies Inc., purchased 27,625 shares of common stock on August 14, 2026 for $3.62 per share.
NASDAQ
Peter Mcnamara, Chief Scientific Officer of Tectonic Therapeutic, Inc., sold 43 shares of common stock on August 12, 2026 for $35.00 per share.
NYSE
Jeremy King, a Director of Wayfair Inc., received 2,422 shares of common stock on August 12, 2026.
NYSE
Andrea Jung, a Director of Wayfair Inc., received 2,422 shares of common stock on August 12, 2026.
NASDAQ
Form 4: Disc Medicine COO Sells Shares
Jonathan Yen-Wen Yu, Chief Operating Officer of Disc Medicine, Inc., sold 804 shares of common stock on August 12, 2026 for $82.64 per share.
NYSE
Cary D Baetz, EVP and CFO of Infinity Natural Resources, Inc., reported multiple transactions in common stock on August 12, 2026.
NASDAQ
Jennifer Kayden Lee, EVP, Head of North America of Rhythm Pharmaceuticals, Inc., sold 75,834 shares of common stock on August 13, 2026 for $117.38 per share.
NASDAQ
Yann Mazabraud, EVP, Head of International of Rhythm Pharmaceuticals, Inc., sold 57,000 shares of common stock on August 12, 2026.
NYSE
SNOW
Snowflake INCForm 4: Snowflake Director Sells Shares
Benoit Dageville, a Director of Snowflake Inc., sold 50,000 shares of common stock on August 12, 2026 for $335.70 per share.
NASDAQ
Richard Mora, a Director of Enphase Energy, Inc., sold 1,500 shares of common stock on August 14, 2026 for $40.36 per share.
NASDAQ
Susan E. Atkins, a Director of BioXcel Therapeutics, Inc., received 17,000 shares of common stock on August 12, 2026.
NASDAQ
APPF
Appfolio INCForm 4: Appfolio Insider Sells Shares
Maurice J Duca, a 10% owner of Appfolio Inc, sold 6,693 shares of common stock on August 12, 2026.